Disease activity in patients with immune-mediated inflammatory diseases after SARS-CoV-2 vaccinations

被引：13

作者：

van Dam, Koos P. J. ^{[1
]}

Wieske, Luuk ^{[1
,2
]}

Stalman, Eileen W. ^{[1
]}

Kummer, Laura Y. L. ^{[1
,3
]}

Roosen, Jesse ^{[1
]}

van Kempen, Zoe L. E. ^{[4
]}

Killestein, Joep ^{[4
]}

Volkers, Adriaan G. ^{[5
]}

Boekel, Laura ^{[6
]}

Wolbink, Gerrit J. ^{[6
]}

van der Kooi, Anneke J. ^{[1
]}

Raaphorst, Joost ^{[1
]}

Lowenberg, Mark ^{[5
]}

Takkenberg, R. Bart ^{[5
]}

D'Haens, Geert R. A. M. ^{[5
]}

Spuls, Phyllis I. ^{[7
]}

Bekkenk, Marcel W. ^{[7
]}

Musters, Annelie H. ^{[7
]}

Post, Nicoline F. ^{[7
]}

Bosma, Angela L. ^{[7
]}

Hilhorst, Marc L. ^{[8
]}

Vegting, Yosta ^{[8
]}

Bemelman, Frederike J. ^{[8
]}

Voskuyl, Alexandre E. ^{[9
]}

Broens, Bo ^{[9
]}

Sanchez, Agner Parra ^{[9
,10
]}

van Els, Cecile A. C. M. ^{[11
,12
]}

de Wit, Jelle ^{[11
]}

Rutgers, Abraham ^{[13
]}

de Leeuw, Karina ^{[13
]}

Horvath, Barbara ^{[14
]}

Verschuuren, Jan J. G. M. ^{[15
]}

Ruiter, Annabel M. ^{[15
]}

van Ouwerkerk, Lotte ^{[16
]}

van der Woude, Diane ^{[16
]}

Allaart, Renee C. F. ^{[16
]}

Teng, Y. K. Onno ^{[17
]}

van Paassen, Pieter ^{[18
]}

Busch, Matthias H. ^{[18
]}

Jallah, Papay B. P. ^{[18
]}

Brusse, Esther ^{[19
]}

van Doorn, Pieter A. ^{[19
]}

Baars, Adaja E. ^{[19
]}

Hijnen, Dirk Jan ^{[20
]}

Schreurs, Corine R. G. ^{[20
]}

van der Pol, W. Ludo ^{[21
]}

Goedee, H. Stephan ^{[21
]}

Steenhuis, Maurice ^{[3
]}

Keijzer, Sofie ^{[3
]}

Keijser, Jim B. D. ^{[3
]}

机构：

[1] Univ Amsterdam, Dept Neurol & Neurophysiol, Amsterdam Neurosci, Amsterdam UMC, Amsterdam, Netherlands

[2] St Antonius Hosp, Dept Clin Neurophysiol, Nieuwegein, Netherlands

[3] Amsterdam UMC, Dept Immunopathol, Sanquin Res & Landsteiner Lab, Amsterdam, Netherlands

[4] Vrije Univ Amsterdam, Dept Neurol, Amsterdam UMC, Med Ctr, Amsterdam, Netherlands

[5] Univ Amsterdam, Acad Med Ctr, Dept Gastroenterol & Hepatol, Amsterdam UMC, Amsterdam, Netherlands

[6] Reade, Amsterdam Rheumatol & Immunol Ctr, Dept Rheumatol, Amsterdam, Netherlands

[7] Univ Amsterdam, Acad Med Ctr, Dept Dermatol, Amsterdam UMC, Amsterdam, Netherlands

[8] Univ Amsterdam, Acad Med Ctr, Dept Internal Med, Sect Nephrol, Amsterdam, Netherlands

[9] Vrije Univ Amsterdam, Amsterdam Rheumatol & Immunol Ctr, Dept Rheumatol & Clin Immunol, Med Ctr, Amsterdam, Netherlands

[10] Univ Amsterdam, Amsterdam Rheumatol & Immunol Ctr, Dept Rheumatol & Clin Immunol, Amsterdam UMC, Amsterdam, Netherlands

[11] Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control, Bilthoven, Netherlands

[12] Univ Utrecht, Fac Vet Med, Utrecht, Netherlands

[13] Univ Med Ctr Groningen, Dept Rheumatol & Clin Immunol, Groningen, Netherlands

[14] Univ Groningen, Univ Med Ctr Groningen, Ctr Blistering Dis, Dept Dermatol, Groningen, Netherlands

[15] Leiden Univ, Dept Neurol, Med Ctr, Leiden, Netherlands

[16] Leiden Univ, Dept Rheumatol, Med Ctr, Leiden, Netherlands

[17] Leiden Univ, Ctr Expertise Lupus Vasculitis & Complement Media, Dept Internal Med Nephrol Sect, Med Ctr, Leiden, Netherlands

[18] Maastricht Univ, Dept Nephrol & Clin Immunol, Med Ctr, Maastricht, Netherlands

[19] Univ Med Ctr, Dept Neurol, Erasmus MC, Rotterdam, Netherlands

[20] Univ Med Ctr, Dept Dermatol, Erasmus MC, Rotterdam, Netherlands

[21] UMC Utrecht, Dept Neurol & Neurosurg, Brain Ctr, Utrecht, Netherlands

[22] Univ Amsterdam, Swammerdam Inst Life Sci, Amsterdam, Netherlands

[23] Univ Amsterdam, Dept Pediat Immunol Rheumatol & Infect Dis, Amsterdam UMC, AMC, Amsterdam, Netherlands

来源：

JOURNAL OF AUTOIMMUNITY | 2023年 / 135卷

关键词：

SARS-CoV-2; COVID-19; Vaccination; Autoimmune disease; Disease activity; Flare;

D O I：

10.1016/j.jaut.2022.102984

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

For patients with immune-mediated inflammatory diseases (IMIDs), concerns exist about increased disease ac-tivity after vaccination. We aimed to assess changes in disease activity after SARS-CoV-2 vaccination in patients with IMIDs, and determine risk factors for increased disease activity. In this substudy of a prospective obser-vational cohort study (Target-to-B!), we included patients with IMIDs who received a SARS-CoV-2 vaccine. Patients reported changes in disease activity on a five-point Likert scale every 60 days for up to twelve months after first vaccination. In case of self-reported increased activity, hospital records were screened whether the treating physician reported increased activity, and for potential intensification of immunosuppressive (ISP) treatment. Mixed models were used to study determinants for self-reported increased disease activity. In total, 2111 patients were included for analysis after primary immunization (mean age 49.7 years [SD 13.7], 1329/ 2111 (63.0%) female), from which 1266 patients for analysis after first additional vaccination. Increased disease activity at 60 days after start of primary immunization was reported by 223/2111 (10.6%). In 96/223 (43.0%) the increase was confirmed by the treating physician and in 36/223 (16.1%) ISP treatment was intensified. Increased disease activity at seven to 60 days after additional vaccination, was reported by 139/1266 (11.0%). Vaccinations were not temporally associated with self-reported increased disease activity. Conversely, increased disease activity before first vaccination, neuromuscular disease, and multiple sclerosis were associated. Alto-gether, self-reported increased disease activity after vaccination against SARS-CoV-2 was recorded in a minority of patients and was generally mild. Moreover, multivariate analyses suggest that disease related factors, but not vaccinations are the major determinants for self-reported increased disease activity.

引用

页数：9

共 50 条

[31] Impact of systemic therapies on SARS-CoV-2 antibody seroprevalence in patients with immune-mediated diseases
Romero-Bogado, Liz
Steiner, Martina
Vasallo, Israel John Thuissard
Vazquez, Cristina Andreu
Navio, Teresa
Munoz-Fernandez, Santiago
MEDICINA CLINICA, 2024, 162 (10): : 470 - 476
[32] Immune-mediated implications of SARS-CoV-2 in breast cancer patients
Mitova, V.
Gavrilov, I.
Gornev, R.
Plachkova, M. D.
Pakataridis, P.
Atanasov, T.
BREAST, 2023, 68 : S118 - S118
[33] Risk factors associated with short-term adverse events after SARS-CoV-2 vaccination in patients with immune-mediated inflammatory diseases
Wieske, Luuk
Kummer, Laura Y. L.
van Dam, Koos P. J.
Stalman, Eileen W.
van der Kooi, Anneke J.
Raaphorst, Joost
Lowenberg, Mark
Takkenberg, R. Bart
Volkers, Adriaan G.
D'Haens, Geert R. A. M.
Tas, Sander W.
Spuls, Phyllis, I
Bekkenk, Marcel W.
Musters, Annelie H.
Post, Nicoline F.
Bosma, Angela L.
Hilhorst, Marc L.
Vegting, Yosta
Bemelman, Frederike J.
Killestein, Joep
van Kempen, Zoe L. E.
Voskuyl, Alexandre E.
Broens, Bo
Sanchez, Agner Parra
Wolbink, Gertjan
Boekel, Laura
Rutgers, Abraham
de Leeuw, Karina
Horvath, Barbara
Verschuuren, Jan J. G. M.
Ruiter, Annabel M.
van Ouwerkerk, Lotte
van der Woude, Diane
Allaart, Cornelia F.
Teng, Y. K. Onno
van Paassen, Pieter
Busch, Matthias H.
Jallah, B. Papay
Brusse, Esther
van Doorn, Pieter A.
Baars, Adaja E.
Hijnen, Dirkjan
Schreurs, Corine R. G.
van der Pol, W. Ludo
Goedee, H. Stephan
Steenhuis, Maurice
Rispens, Theo
Ten Brinke, Anja
Verstegen, Niels J. M.
Zwinderman, Koos A. H.
BMC MEDICINE, 2022, 20 (01)
[34] Risk factors associated with short-term adverse events after SARS-CoV-2 vaccination in patients with immune-mediated inflammatory diseases
Luuk Wieske
Laura Y. L. Kummer
Koos P. J. van Dam
Eileen W. Stalman
Anneke J. van der Kooi
Joost Raaphorst
Mark Löwenberg
R. Bart Takkenberg
Adriaan G. Volkers
Geert R. A. M. D’Haens
Sander W. Tas
Phyllis I. Spuls
Marcel W. Bekkenk
Annelie H. Musters
Nicoline F. Post
Angela L. Bosma
Marc L. Hilhorst
Yosta Vegting
Frederike J. Bemelman
Joep Killestein
Zoé L. E. van Kempen
Alexandre E. Voskuyl
Bo Broens
Agner Parra Sanchez
Gertjan Wolbink
Laura Boekel
Abraham Rutgers
Karina de Leeuw
Barbara Horváth
Jan J. G. M. Verschuuren
Annabel M. Ruiter
Lotte van Ouwerkerk
Diane van der Woude
Cornelia F. Allaart
Y. K. Onno Teng
Pieter van Paassen
Matthias H. Busch
B. Papay Jallah
Esther Brusse
Pieter A. van Doorn
Adája E. Baars
Dirkjan Hijnen
Corine R. G. Schreurs
W. Ludo van der Pol
H. Stephan Goedee
Maurice Steenhuis
Theo Rispens
Anja ten Brinke
Niels J. M. Verstegen
Koos A. H. Zwinderman
BMC Medicine, 20
[35] Intensity and longevity of SARS-CoV-2 vaccination response in patients with immune-mediated inflammatory disease: a prospective cohort study
Simon, David
Tascilar, Koray
Fagni, Filippo
Kleyer, Arnd
Kroenke, Gerhard
Meder, Christine
Dietrich, Peter
Orlemann, Till
Moessner, Johanna
Taubmann, Jule
Mutlu, Melek Yalcin
Knitza, Johannes
Kemenes, Stephan
Liphardt, Anna-Maria
Schoenau, Verena
Bohr, Daniela
Schuster, Louis
Hartmann, Fabian
Minopoulou, Ioanna
Leppkes, Moritz
Ramming, Andreas
Pachowsky, Milena
Schuch, Florian
Ronneberger, Monika
Kleinert, Stefan
Hueber, Axel J.
Manger, Karin
Manger, Bernhard
Atreya, Raja
Berking, Carola
Sticherling, Michael
Neurath, Markus F.
Schett, Georg
LANCET RHEUMATOLOGY, 2022, 4 (09): : E614 - E625
[36] The effect of exposure to SARS-CoV-2 vaccination and infection on humoral and cellular immunity in a cohort of patients with immune-mediated inflammatory diseases
Costanzo, G.
Deiana, C. M.
Miglianti, M.
Sanna, G.
Ennas, M.
Perra, A.
Campagna, M.
Littera, R.
Sambugaro, G.
Fenu, G.
Palmas, V.
Cappai, R.
Dessi, M.
Coghe, F.
Manzin, A.
Del Giacco, S.
Chessa, L.
Firinu, D.
ALLERGY, 2023, 78
[37] Third dose corrects waning immunity to SARS-CoV-2 mRNA vaccines in immunocompromised patients with immune-mediated inflammatory diseases
Cheung, Michelle W.
Dayam, Roya M.
Law, Jaclyn C.
Goetgebuer, Rogier L.
Chao, Gary Y. C.
Finkelstein, Naomi
Stempak, Joanne M.
Pereira, Daniel
Croitoru, David
Acheampong, Lily
Rizwan, Saima
Lee, Jenny D.
Ganatra, Darshini
Law, Ryan
Delgado-Brand, Melanie
Mailhot, Genevieve
Piguet, Vincent
Silverberg, Mark S.
Watts, Tania H.
Gingras, Anne-Claude
Chandran, Vinod
RMD OPEN, 2022, 8 (02):
[38] Efficacy and safety of SARS-CoV-2 revaccination in non-responders with immune-mediated inflammatory disease
Simon, David
Tascilar, Koray
Fagni, Filippo
Schmidt, Katja
Kroeneke, Gerhard
Kleyer, Arnd
Ramming, Andreas
Schoenau, Verena
Bohr, Daniela
Knitza, Johannes
Harrer, Thomas
Manger, Karin
Manger, Bernhard
Schett, Georg
ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 (07) : 1023 - 1027
[39] Third and Fourth Vaccine Doses Broaden and Prolong Immunity to SARS-CoV-2 in Adult Patients with Immune-Mediated Inflammatory Diseases
Cheung, Michelle W.
Dayam, Roya M.
Shapiro, Janna R.
Law, Jaclyn C.
Chao, Gary Y. C.
Pereira, Daniel
Goetgebuer, Rogier L.
Croitoru, David
Stempak, Joanne M.
Acheampong, Lily
Rizwan, Saima
Lee, Jenny D.
Jacob, Liz
Ganatra, Darshini
Law, Ryan
Rodriguez-Castellanos, Victoria E.
Kern-Smith, Madeline
Delgado-Brand, Melanie
Mailhot, Genevieve
Haroon, Nigil
Inman, Robert D.
Piguet, Vincent
Chandran, Vinod
Silverberg, Mark S.
Watts, Tania H.
Gingras, Anne-Claude
JOURNAL OF IMMUNOLOGY, 2023, 211 (03): : 351 - 364
[40] SARS-CoV-2 vaccination responses in untreated, conventionally treated and anticytokine-treated patients with immune-mediated inflammatory diseases
Simon, David
Tascilar, Koray
Fagni, Filippo
Kroenke, Gerhard
Kleyer, Arnd
Meder, Christine
Atreya, Raja
Leppkes, Moritz
Kremer, Andreas E.
Ramming, Andreas
Pachowsky, Milena L.
Schuch, Florian
Ronneberger, Monika
Kleinert, Stefan
Hueber, Axel J.
Manger, Karin
Manger, Bernhard
Berking, Carola
Sticherling, Michael
Neurath, Markus F.
Schett, Georg
ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 (10) : 1312 - 1316

← 1 2 3 4 5 →